DAIICHI SANKYO COMPANY, LIMITEDTokyo Japan
Company Description
Daiichi Sankyo is a leader in the Japanese pharmaceuticals business. The company manufactures prescription drugs, including treatments for cardiovascular, bone and joint, autoimmune, metabolic, and infectious diseases. Top products include Olmetec for hypertension and Loxonin for inflammation. Daiichi Sankyo also makes over-the-counter (OTC) and generic drugs through subsidiaries including Daiichi Sankyo Healthcare and majority owned
| 3-5-1 Nihombashi-Honcho, Chuo-Ku | Phone: +81-3-6255-1126 | http://www.daiichisankyo.co.jp |
| Tokyo 103-8426 | Fax: +81-3-6255-1132 | |
| Japan |
DAIICHI SANKYO COMPANY, LIMITED Rankings
| Nikkei 225 |
Executives
| 29 executives listed for DAIICHI SANKYO COMPANY, LIMITED's Tokyo, Japan location. | ||
| Managing Director, Ranbaxy Laboratories | Arun Sawhney | |
|---|---|---|
| VP Human Resources, Daiichi Sankyo, Inc. | Danesha Dixon Smith | |
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | March |
| 2011 Employees | 30,488 |
More DAIICHI SANKYO COMPANY, LIMITED Financials
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on DAIICHI SANKYO COMPANY, LIMITED now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
